3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
3
Unknown
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
1
Conditions
Rectal Neoplasms
10
Colorectal Neoplasms
10
Stomach Neoplasms
8
Colonic Neoplasms
7
Ovarian Neoplasms
3
Gastrointestinal Stromal Tumors
3
Liver Neoplasms
2
Kidney Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma, Hepatocellular
2
Venous Thrombosis
1
Urinary Incontinence
1
Surgical Wound Infection
1
Sexual Dysfunction, Physiological
1
Peritoneal Neoplasms
1
Neuroendocrine Tumors
1
Neoplastic Cells, Circulating
1
Neoplasms
1
Malignant Neoplasm of Transverse Colon
1
Locally Advanced Gastric Cancer
1
Liver Diseases
1
Inflammatory Bowel Diseases
1
Gastrointestinal Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Erectile Dysfunction
1
Endometrial Neoplasms
1
Diverticulum
1
Colorectal Liver Metastasis
1
Cholecystolithiasis
1
Carcinoma, Pancreatic Ductal
1
Interventions
Exercise
18
Drug Therapy
17
pembrolizumab
12
Capecitabine
11
Blood Specimen Collection
11
Surveys and Questionnaires
10
Radiotherapy
10
Dexamethasone
9
Paclitaxel
8
Standard of Care
7
Oxaliplatin
7
Nivolumab
7
Fluorouracil
7
Erlotinib Hydrochloride
7
apatinib
6
Interviews as Topic
6
Gemcitabine
6
Cisplatin
6
Therapeutics
5
Neoadjuvant Therapy
5
Mindfulness-Based Cognitive Therapy
5
Metformin
5
Injections
5
Everolimus
5
Docetaxel
5
Cyclophosphamide
5
Control Groups
5
Bevacizumab
5
sintilimab
4
atezolizumab
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Neoplasms
×
Laparoscopy
×
Clear all
NCT04950140
2021-07-06
LAROPA
Instituto do Cancer do Estado de São Paulo
Phase NA
Unknown
40 enrolled